Christopher Downs - 22 Aug 2023 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Chief Financial Officer
Signature
/s/ Christopher Downs
Issuer symbol
CNSP
Transactions as of
22 Aug 2023
Net transactions value
+$34,177
Form type
4
Filing time
23 Aug 2023, 08:00:04 UTC
Previous filing
01 May 2023
Next filing
06 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNSP Common Stock Purchase $34,177 +27,000 +276% $1.27 36,772 22 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $1.2196 to $1.2999. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.